Prescription Required
Formulation: Powder Inhalation
(Brand Option)
Select the prescribed dosage
Select the quantity to see the price.
Prescription Required
Formulation: Powder Inhalation
Select the quantity to see the price.
* This price includes a dispensing fee, medical review fee, and packing fee.
Shipped and delivered directly to your doorstep
Incruse Ellipta (active ingredient: umeclidinium bromide) is a prescription inhaler used for the long-term maintenance treatment of chronic obstructive pulmonary disease (COPD) in adults.
It helps keep the airways open, making it easier to breathe and reducing everyday COPD symptoms. Incruse Ellipta is not a rescue inhaler and should not be used to relieve sudden breathing problems or asthma attacks.
COPD is a long-term lung disease that makes it difficult to breathe. It includes conditions such as:
Common symptoms of COPD include:
When used every day, Incruse Ellipta helps improve breathing and may reduce COPD flare-ups (exacerbations), allowing many people to stay more active.
Incruse Ellipta belongs to a group of medications called long-acting muscarinic antagonists (LAMAs), also known as long-acting anticholinergic bronchodilators.
It works by blocking the action of acetylcholine, a natural chemical that causes the muscles around the airways to tighten.
By relaxing these airway muscles, Incruse Ellipta helps:
Each dose provides 24-hour bronchodilation, so the inhaler is typically used once daily.
For the best results, use Incruse Ellipta every day, even if you are feeling well. Remember that it is a maintenance inhaler and will not provide immediate relief during a sudden breathing attack. Always keep your rescue inhaler (such as albuterol/salbutamol), if prescribed, available for sudden breathing problems.
Incruse Ellipta is an inhalation powder that is inhaled through the Ellipta inhaler. It should be used once daily, exactly as prescribed by your healthcare provider.
Take one inhalation at the same time each day. Do not use more than one dose in a 24-hour period unless instructed by your healthcare provider.
Only open the inhaler when you are ready to take your dose.
Opening the cover prepares a dose of medication. If you open and close the inhaler without inhaling the medication, the prepared dose will be lost and cannot be used.
To avoid wasting a dose:
While inhaling, you may or may not taste or feel the medication. This is normal and does not mean your dose was not delivered.
Do not breathe out into the inhaler, as moisture from your breath can damage the powder inside the device.
Incruse Ellipta (Umeclidinium Bromide) is available in the following forms and strengths:
Before using Incruse Ellipta, tell your healthcare provider about your complete medical history, including any allergies, medical conditions, and all medications you are taking. This helps ensure the medication is safe and appropriate for you.
Do not use Incruse Ellipta if you are allergic to umeclidinium bromide, milk proteins, or any of the other ingredients in the inhaler.
The inhalation powder contains milk proteins, which may cause serious allergic reactions in people with severe milk protein allergies.
Seek emergency medical attention immediately if you develop signs of a serious allergic reaction, including:
Incruse Ellipta is a maintenance inhaler and is not a rescue medication.
It does not work quickly enough to relieve sudden breathing problems or a COPD flare-up. If you experience sudden shortness of breath, use your fast-acting rescue inhaler (such as albuterol/salbutamol) as directed by your healthcare provider.
Seek immediate medical attention if your rescue inhaler does not relieve your symptoms or if your breathing suddenly worsens.
Before using Incruse Ellipta, tell your healthcare provider if you have or have ever had:
Because umeclidinium has anticholinergic effects, it may worsen these conditions in some people.
If you are pregnant, planning to become pregnant, or breastfeeding, tell your healthcare provider before using Incruse Ellipta.
There is limited information about the use of umeclidinium during pregnancy and breastfeeding. Your healthcare provider will determine whether the benefits of treatment outweigh any potential risks for you and your baby.
Use Incruse Ellipta every day as prescribed, even if you feel well. Do not stop using the inhaler without first consulting your healthcare provider, as your COPD symptoms may worsen.
If you notice your symptoms are getting worse or you need to use your rescue inhaler more often than usual, contact your healthcare provider promptly, as your treatment plan may need to be adjusted.
Incruse Ellipta is used by inhaling the medication through your mouth using the Ellipta inhaler. Take one inhalation once daily, exactly as prescribed by your healthcare provider. Open the inhaler only when you are ready to take your dose, and follow the instructions provided with the device to ensure you receive the full dose.
Incruse Ellipta begins working soon after you inhale a dose by helping to relax the muscles around your airways. However, it is designed for long-term maintenance treatment, not for immediate relief of breathing problems. With daily use, you should notice easier breathing and better control of your COPD symptoms over time.
If you are pregnant, planning to become pregnant, or breastfeeding, talk to your healthcare provider before using Incruse Ellipta. They will discuss the potential benefits and risks to determine whether this medication is appropriate for you.
Yes, but some medications may interact with Incruse Ellipta. Before starting treatment, tell your healthcare provider about all prescription medications, over-the-counter medicines, vitamins, and herbal supplements you are taking. This will help them identify any potential drug interactions.
The usual dose is one inhalation once daily. Use the inhaler at the same time each day and do not use more than one dose in a 24-hour period unless instructed by your healthcare provider.
No. Continue using Incruse Ellipta exactly as prescribed, even if your breathing improves. It is a maintenance medication that helps keep your airways open over time. Stopping the medication without consulting your healthcare provider may cause your COPD symptoms to worsen.
| Generic name: | Umeclidinium Bromide |
|---|---|
| Formulation: | Powder Inhalation |
| Strength(s): | 62.5mcg |
| Quantities Available: | 90doses |
Our online Canadian Pharmacy is known for high standards of quality, safety, and efficiency when it comes to medications.
Our pharmacy offers lower prices on prescription drugs compared to traditional pharmacies.
When ordering Incruse Ellipta (umeclidinium) from a Canadian pharmacy, you can typically purchase up to a 90-day supply at one time, which is common for prescription medications to ensure adequate management of chronic conditions without frequent refills.
Here’s what you need to know:
Dosage and Quantity: Incruse Ellipta is available in 30, 60, or 90 doses of powder inhalation with 62.5 mcg strength and is typically prescribed as one inhalation once daily. For a 90-day supply, you would order either one inhaler with 90 doses, two inhalers with 60 doses each, or three inhalers with 30 doses each, depending on availability and your preference.
No, we don’t sell umeclidinium. However, you can still enjoy low prices on Incruse Ellipta, which contains umeclidinium as an active ingredient. To order, you’ll need a valid prescription from your healthcare provider, as we require this to dispense the medication safely and accurately. You can conveniently submit your prescription by mail, fax, or by uploading it through your online account during the ordering process.
Yes, we ship Incruse Ellipta (umeclidinium) to both the United States and Puerto Rico.
Watch how Online Pharmacies Canada is helping customers save money on their medications.
Online Pharmacies Canada has provided information from third parties intended to increase awareness and does not contain all the information about Incruse Ellipta (Umeclidinium Bromide). Talk to your doctor or other qualified medical practitioners for medical attention or advice, or if you have any concerns about Incruse Ellipta (Umeclidinium Bromide).
REVIEWS